N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01138137
Recruitment Status : Withdrawn (No funding was available for the cost of the IV N-acetylcysteine (NAC).)
First Posted : June 7, 2010
Last Update Posted : April 21, 2017
Information provided by (Responsible Party):
Edward Neuwelt, OHSU Knight Cancer Institute

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : December 2014
  Study Completion Date : December 2014